Answer
Sorafenib tosilate should not be used during pregnancy unless clearly necessary, after careful consideration of the mother's needs and fetal risk, because fetal harm is anticipated and there are no data in pregnant women.
Sources for this answer
- Nexavar 200mg film-coated tabletsBayer plc · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 32Document updated
Sources checked